Paulo Fontoura.

No events began in the chosen period. Widen it, or reset.

• Sanofi Structural
  Sanofi and Recursion Pharmaceuticals formed a partnership to develop AI-enabled therapies.
  Moves Paulo Fontoura

  Fri 00:46
• Hoffmann-La Roche Structural
  Hoffmann-La Roche and Danaher are partnering with Nvidia to develop AI-driven labs for R&D and advance autonomous science.
  Moves Paulo Fontoura

  Sun 11:57
• Sanofi Structural
  A partnership involving Recursion Pharmaceuticals, Sanofi, Roche, Merck, and Relay Therapeutics diversifies pipelines across oncology and immunology, leveraging AI-driven platforms.
  Moves Paulo Fontoura

  Mon 16:16
• FDA Operational
  TraceLink advances multinational compliance roadmaps in Egypt and Ethiopia while addressing FDA's transition to 12-digit National Drug Code.
  Moves Paulo Fontoura

  08:01

• Sanofi Structural

  Sanofi formally employed Paulo Fontoura as EVP, Global Head of R&D Pharma.

  Some supportJun 28
  Paulo Fontoura → Sanofi

  Sanofi → Paulo Fontoura
• Hoffmann-La Roche Structural

  Paulo Fontoura was employed by Hoffmann-La Roche for 15 years.

  Some supportJun 23
  Paulo Fontoura → Hoffmann-La Roche

  Hoffmann-La Roche → Paulo Fontoura
• Sanofi Structural

  Paulo Fontoura holds an R&D head position at Sanofi.

  Some supportSep 21
  Paulo Fontoura → Sanofi

  Sanofi → Paulo Fontoura
• Houman Ashrafian Structural

  Paulo Fontoura is scheduled to replace Houman Ashrafian in R&D leadership.

  Some supportJun 28
  Paulo Fontoura → Houman Ashrafian

  Houman Ashrafian → Paulo Fontoura
• FDA Operational

  Paulo Fontoura's contributions influenced successful FDA and EMA regulatory approvals.

  Some supportJun 23
  Paulo Fontoura → FDA

  FDA → Paulo Fontoura